Article
[The efficacy of sorafenib to prevent relapse in patients with FLT3-ITD mutation positive acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation].
Zhonghua nei ke za zhi - 1 Aug 2016
Zu Y L, Zhang Y L, Zhou J, Han L J, Zhao H F, Gui R R, Hou Y J, Song Y P
Abstract excerpt
To study the efficacy of sorafenib to prevent relapse in patients with FLT3-ITD mutation positive acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). A total of 7 cases with FLT3-ITD positive AML have received allo-HSCT in our department from May 2013 to January 2015. Six cases were administrated with sorafenib after hematopoietic reconstruction. Another patient...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.